Brief: Jiangsu Hengrui Medicine in licensing agreement with Japan's Oncolys Biopharma
02/12/2016 11:20
Dec 2 (Reuters) - Jiangsu Hengrui Medicine Co Ltd
600276.SS
* Says it signs licensing agreement with Japan's Oncolys
Biopharma 4588.T on medicine telomelysin's sales in China,
Hong Kong and Macau
Source text in Chinese: http://bit.ly/2gPt1wc
Further company coverage: 600276.SS
(Reporting by Hong Kong newsroom)
((hongkong.newsroom@thomsonreuters.com; (852) 2843-6441;
Reuters Messaging: chyenyee.lee.reuters.com@reuters.net))